Precigen is trading 4.45% up now at $7.75, with the move appearing primarily sector-driven as biotech ETF XBI gains 2.55%.
- Precigen rose 6.21% on September 16, 2026.
- No fresh company-specific announcement was identified for September 17; recent indexed coverage centers on earlier earnings and pipeline developments.
- Broader gains in the S&P 500 and Nasdaq accompanied the move; trading volume and activity details were unavailable from the provided context.